Drawing for BUCOANGIN

USPTO serial 99264889

BUCOANGIN

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
Examiner
DIGAN, MATTHEW M

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Need help with BUCOANGIN?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

Owner

  • Top Health Pharmaceuticals Corp

    Sheridan, WY, US

  • Top Health Pharmaceuticals Corp

    Sheridan, WY, US

Goods and services

ClassDescriptionStatusFirst use
005Throat lozengesACTIVE

Prosecution history

DateCodeEvent
Jul 30, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 30, 2026EX1GSOU EXTENSION 1 GRANTED
Jul 29, 2026EXT1SOU EXTENSION 1 FILED
Jul 29, 2026EEXTSOU TEAS EXTENSION RECEIVED
Feb 10, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 16, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2025PUBOPUBLISHED FOR OPPOSITION
Dec 10, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2025DOCKASSIGNED TO EXAMINER
Nov 7, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Jul 2, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance